FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Griseofulvin 125mg/5ml oral suspension (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Griseofulvin 125mg/5ml oral suspension 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Griseofulvin 125mg/5ml oral suspension (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 10 milligram/1 gram and oxytetracycline (as oxytetracycline hydrochloride) 30 milligram/1 gram conventional release cutaneous ointment VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Oleum rhinale nasal drops VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxytetracycline 3% / Hydrocortisone 1% ointment 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oleum rhinale nasal drops (Weleda (UK) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Terra-Cortril ointment (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Terra-Cortril ointment (Esteve Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oxytetracycline 3% / Hydrocortisone 1% ointment 15 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Oleum rhinale nasal drops 15 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Terra-Cortril ointment (Esteve Pharmaceuticals Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Terra-Cortril ointment (Pfizer Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oleum rhinale nasal drops (Weleda (UK) Ltd) 15 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Terra-Cortril ointment (Pfizer Ltd) 15 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely nabilone 500 microgram/1 each conventional release oral capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Magnesium glycerophosphate 121.25mg/5ml (magnesium 5mmol/5ml) oral solution sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nabilone 500microgram capsules (Cambridge Laboratories) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Magnesium glycerophosphate 121.25mg/5ml (magnesium 5mmol/5ml) oral solution sugar free 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nabilone 500microgram capsules (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution sugar free 250 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nabilone 500microgram capsules 1 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
MagnaPhate 121.25mg/5ml (magnesium 5mmol/5ml) oral solution (Arjun Products Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Magnesium glycerophosphate 121.25mg/5ml (magnesium 5mmol/5ml) oral solution sugar free (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution sugar free 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nabilone 500microgram capsules 20 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Magnesium glycerophosphate 121.25mg/5ml (magnesium 5mmol/5ml) oral solution sugar free 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
LiquaMag GP (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution (Fontus Health Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nabilone 500microgram capsules (Cambridge Laboratories) 20 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution sugar free (Special Order) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
LiquaMag GP (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution (Fontus Health Ltd) 250 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nabilone 500microgram capsules (Special Order) 1 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Magnesium glycerophosphate 121.25mg/5ml (magnesium 5mmol/5ml) oral solution sugar free (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
MagnaPhate 121.25mg/5ml (magnesium 5mmol/5ml) oral solution (Arjun Products Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely promazine hydrochloride 50 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml solution for injection vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Approved Prescription Services) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Eloxatin 200mg/40ml concentrate for solution for infusion vials (sanofi-aventis) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Accord Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets 250 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Accord Healthcare Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (A A H Pharmaceuticals Ltd) 250 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (A A H Pharmaceuticals Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Unichem Plc) 250 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Teva UK Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Eloxatin 200mg/40ml concentrate for solution for infusion vials (sanofi-aventis) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Approved Prescription Services) 250 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Kent Pharma (UK) Ltd) 250 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Kent Pharma (UK) Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 40mg gastro-resistant capsules (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 20mg gastro-resistant capsules (Alliance Healthcare (Distribution) Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Esomeprazole 40mg gastro-resistant capsules (Alliance Healthcare (Distribution) Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 2% gel 100 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 2% gel (Special Order) 100 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
PanOxyl 5 lotion (Stiefel Laboratories Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Benzoyl peroxide 5% lotion 30 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxy 5 lotion (GlaxoSmithKline Consumer Healthcare) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Oxy 5 lotion (GlaxoSmithKline Consumer Healthcare) 30 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
PanOxyl 5 lotion (Stiefel Laboratories Ltd) 30 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Centrum Fruity Chewables tablets (Haleon UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Centrum Fruity Chewables tablets (Haleon UK Ltd) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Macrogol compound oral powder 13.8g sachets NPF VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Laxido Orange oral powder 13.8g sachets (Galen Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Macroherm oral powder 13.8g sachets (Ennogen Pharma Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Macrogol compound oral powder 13.8g sachets NPF 30 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Macrogol compound oral powder 13.8g sachets NPF 20 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Laxido Orange oral powder 13.8g sachets (Galen Ltd) 30 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Macroherm oral powder 13.8g sachets (Ennogen Pharma Ltd) 30 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Laxido Orange oral powder 13.8g sachets (Galen Ltd) 20 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Macroherm oral powder 13.8g sachets (Ennogen Pharma Ltd) 20 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (A A H Pharmaceuticals Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely metolazone 5 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ispaghula husk 3.5g granules sachets gluten free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ispaghula husk 3.5g granules sachets gluten free (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 50 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zaroxolyn 5mg tablets (Imported (Canada)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metolazone 5mg tablets 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ispaghula husk 3.5g granules sachets gluten free 10 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fibrelief Orange 3.5g granules sachets (Manx Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ispaghula husk 3.5g granules sachets gluten free 30 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fibrelief Orange 3.5g granules sachets (Manx Healthcare Ltd) 10 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ispaghula husk 3.5g granules sachets gluten free (A A H Pharmaceuticals Ltd) 30 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) 100 tablet 10 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fibrelief Orange 3.5g granules sachets (Manx Healthcare Ltd) 30 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zaroxolyn 5mg tablets (Imported (Canada)) 50 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 250microgram tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 250microgram tablets (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 250microgram tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 250microgram tablets 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ergocalciferol 250microgram tablets (Celltech Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 51 of 86 Next End

This concept is not in any reference sets

Back to Start